Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | 02-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | N/A | 20,690 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 28,970 |
| Other Working Capital | N/A | N/A | N/A | N/A | 50 |
| Other Operating Activity | 0 | 0 | 0 | 0 | 11,160 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $60,870 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -24,420 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -50 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-24,470 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 0 | 730 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $730 |
| Beginning Cash Position | N/A | N/A | N/A | N/A | 45,810 |
| End Cash Position | N/A | N/A | N/A | N/A | 82,950 |
| Net Cash Flow | $N/A | $N/A | $N/A | $N/A | $37,130 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | N/A | N/A | 60,870 |
| Free Cash Flow | 0 | 0 | 0 | 0 | 60,870 |